Nitricap Medical
Minneapolis, US · Founded 2020 · Delaware corporation
Founders & leadership
JZ
John ZentgrafNamed on SEC filing
PR
Paul RabinovichNamed on SEC filing
AY
Alexander YevzlinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 1 round · 2021
▶$3.2MraisedApr 2021 · 16 investors · Other Health CareRule 506(b)
▶$3.2MraisedApr 2021 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John ZentgrafExecutive Officer, Director
- Paul RabinovichExecutive Officer, Director
- Alexander YevzlinExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.2M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nitricap Medical raised?
- Nitricap Medical has disclosed $3.2M raised across 1 round.
- Where is Nitricap Medical headquartered?
- Nitricap Medical is headquartered in Minneapolis, US.